<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: This study evaluates the effectiveness of three <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MS) criteria in identifying <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) in the Chinese population </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 3598 subjects were recruited from a cohort study on Prevention of Multiple <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">Metabolic disorders</z:e> and MS in Jiangsu of China (PMMJS), followed at 6.3 years </plain></SENT>
<SENT sid="2" pm="."><plain>MS was diagnosed using criteria of the National Cholesterol Education Program's Adult Treatment Panel III (ATPIII), the International <z:mp ids='MP_0002055'>Diabetes</z:mp> Federation (IDF) and Chinese <z:mp ids='MP_0002055'>Diabetes</z:mp> Society (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CDS</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>Cox regression model was used to analysis the association between MS and <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and T2DM </plain></SENT>
<SENT sid="4" pm="."><plain>Receiver operating characteristic (ROC) curve, sensitivity and specificity were also used to test the ability of three MS criteria to identify <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> or T2DM </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among three criteria, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CDS</z:e> has the highest specificity but lowest sensitivity </plain></SENT>
<SENT sid="6" pm="."><plain>Using the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CDS</z:e> criterion, over 50 percent of patients would be misdiagnosed </plain></SENT>
<SENT sid="7" pm="."><plain>ATPIII criterion has the shortest distance in ROC curve, lowest false positive rate and false negative rate for identifying <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and T2DM </plain></SENT>
<SENT sid="8" pm="."><plain>ATPIII+/IDF+ has lower ability to predict <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> than ATPIII+/IDF- </plain></SENT>
<SENT sid="9" pm="."><plain>ATPIII+/IDF+ and ATPIII+/IDF- has similar ability to predict T2DM </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: The ATPIII-MS criterion has the highest ability to predict <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and T2DM </plain></SENT>
<SENT sid="11" pm="."><plain>ATPIII is the best MS criterion for the Chinese population </plain></SENT>
</text></document>